Skip to main content

. 1982 Apr;37(4):309–310. doi: 10.1136/thx.37.4.309

Tocainide-associated interstitial pneumonitis.

A C Braude, E Downar, D W Chamberlain, A S Rebuck

PMCID: PMC459304 PMID: 6810489

309

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bastian B. C., Macfarlane P. W., McLauchlan J. H., Ballantyne D., Clark P., Hillis W. S., Rae A. P., Hutton I. A prospective randomized trial of tocainide in patients following myocardial infarction. Am Heart J. 1980 Dec;100(6 Pt 2):1017–1022. doi: 10.1016/0002-8703(80)90207-0. [DOI] [PubMed] [Google Scholar]
Crystal R. G., Gadek J. E., Ferrans V. J., Fulmer J. D., Line B. R., Hunninghake G. W. Interstitial lung disease: current concepts of pathogenesis, staging and therapy. Am J Med. 1981 Mar;70(3):542–568. doi: 10.1016/0002-9343(81)90577-5. [DOI] [PubMed] [Google Scholar]
Horn H. R., Hadidian Z., Johnson J. L., Vassallo H. G., Williams J. H., Young M. D. Safety evaluation of tocainide in the American Emergency Use Program. Am Heart J. 1980 Dec;100(6 Pt 2):1037–1040. doi: 10.1016/0002-8703(80)90210-0. [DOI] [PubMed] [Google Scholar]
Hutchinson T. A., Leventhal J. M., Kramer M. S., Karch F. E., Lipman A. G., Feinstein A. R. An algorithm for the operational assessment of adverse drug reactions. II. Demonstration of reproducibility and validity. JAMA. 1979 Aug 17;242(7):633–638. [PubMed] [Google Scholar]
Perlow G. M., Jain B. P., Pauker S. G., Zarren H. S., Wistran D. C., Epstein R. L. Tocainide-associated interstitial pneumonitis. Ann Intern Med. 1981 Apr;94(4 Pt 1):489–490. doi: 10.7326/0003-4819-94-4-489. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES